SI1653963T1 - Farmacevtski sestavek piribedila za nazalno aplikacijo - Google Patents

Farmacevtski sestavek piribedila za nazalno aplikacijo

Info

Publication number: SI1653963T1
Authority: SI; Slovenia
Prior art keywords: piribedil; composition; nasal pharmaceutical; nasal; pharmaceutical
Prior art date: 2003-07-17

Application number

SI200430163T

Other languages

English (en)

Inventor

Herve Rolland

Patrick Wuthrich

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-17

Filing date

2004-07-16

Publication date

2007-04-30

2004-07-16 Application filed by Servier Lab filed Critical Servier Lab

2007-04-30 Publication of SI1653963T1 publication Critical patent/SI1653963T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SI200430163T 2003-07-17 2004-07-16 Farmacevtski sestavek piribedila za nazalno aplikacijo SI1653963T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0308712A FR2857594B1 (fr)	2003-07-17	2003-07-17	Composition pharmaceutique pour l'administration par voie nasale de piribedil
PCT/FR2004/001867 WO2005009442A1 (fr)	2003-07-17	2004-07-16	Composition pharmaceutique pour l’administration par voie nasale de piribedil
EP04767691A EP1653963B1 (fr)	2003-07-17	2004-07-16	Composition pharmaceutique nasale de piribedil

Publications (1)

Publication Number	Publication Date
SI1653963T1 true SI1653963T1 (sl)	2007-04-30

Family

ID=33548200

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200430163T SI1653963T1 (sl)	2003-07-17	2004-07-16	Farmacevtski sestavek piribedila za nazalno aplikacijo

Country Status (29)

Country	Link
US (1)	US20060204449A1 (sl)
EP (1)	EP1653963B1 (sl)
JP (1)	JP2007516947A (sl)
KR (1)	KR100807480B1 (sl)
CN (1)	CN100540004C (sl)
AR (1)	AR046808A1 (sl)
AT (1)	ATE349213T1 (sl)
AU (1)	AU2004258714A1 (sl)
BR (1)	BRPI0412681A (sl)
CA (1)	CA2532631C (sl)
CY (1)	CY1106013T1 (sl)
DE (1)	DE602004003955T2 (sl)
DK (1)	DK1653963T3 (sl)
EA (1)	EA011041B1 (sl)
ES (1)	ES2279435T3 (sl)
FR (1)	FR2857594B1 (sl)
GE (1)	GEP20074259B (sl)
HR (1)	HRP20070081T5 (sl)
MA (1)	MA27864A1 (sl)
MX (1)	MXPA06000641A (sl)
MY (1)	MY137747A (sl)
NO (1)	NO332776B1 (sl)
NZ (1)	NZ544460A (sl)
PL (1)	PL1653963T3 (sl)
PT (1)	PT1653963E (sl)
SI (1)	SI1653963T1 (sl)
UA (1)	UA85193C2 (sl)
WO (1)	WO2005009442A1 (sl)
ZA (1)	ZA200600240B (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2010013393A (es) *	2008-06-06	2011-06-21	Pharma Two B Ltd	Composiciones farmaceuticas para el tratamiento de la enfermedad de parkinson.
US20160022572A1 (en) *	2013-03-13	2016-01-28	N To B Ltd.	Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's disease
IT201800005117A1 (it) *	2018-05-07	2019-11-07		Acqua irradiata con energie elettromagnetiche per uso terapeutico

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0689438B1 (en) *	1993-03-26	2003-06-04	Franciscus Wilhelmus Henricus Maria Merkus	Pharmaceutical compositions for intranasal administration of apomorphine
BE1007402A5 (nl) *	1993-03-26	1995-06-06	Adir	Nasale farmaceutische preparaten met progestagene stof.
FR2710268B1 (fr) *	1993-09-22	1995-10-20	Adir	Utilisation de beta-cyclodextrines partiellement méthylées comme promoteurs d'absorption dans la préparation de compositions pharmaceutiques pour l'administration transcutanée de principes actifs.
FR2710265B1 (fr) *	1993-09-22	1995-10-20	Adir	Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
FR2742989B1 (fr) *	1995-12-29	1998-01-23	Adir	Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs
NZ501321A (en) *	1997-03-26	2001-04-27	Franciscus W	Nasal Melatonin composition
EP0900567A3 (en) *	1997-09-05	2001-05-02	Pfizer Products Inc.	Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
US20020002175A1 (en) *	2000-09-19	2002-01-03	Charanjit Behl	Nasal delivery of apomorphine in combination with glycol derivatives
US20040028613A1 (en) *	2001-06-25	2004-02-12	Nastech Pharmaceutical Company Inc	Dopamine agonist formulations for enhanced central nervous system delivery
FR2827516B1 (fr) *	2001-07-19	2003-09-19	Servier Lab	Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone

2003
- 2003-07-17 FR FR0308712A patent/FR2857594B1/fr not_active Expired - Fee Related
2004
- 2004-07-15 AR ARP040102489A patent/AR046808A1/es unknown
- 2004-07-15 MY MYPI20042838A patent/MY137747A/en unknown
- 2004-07-16 CN CNB2004800197495A patent/CN100540004C/zh not_active Expired - Fee Related
- 2004-07-16 BR BRPI0412681-5A patent/BRPI0412681A/pt not_active IP Right Cessation
- 2004-07-16 JP JP2006519966A patent/JP2007516947A/ja active Pending
- 2004-07-16 EA EA200600172A patent/EA011041B1/ru not_active IP Right Cessation
- 2004-07-16 US US10/564,139 patent/US20060204449A1/en not_active Abandoned
- 2004-07-16 ZA ZA200600240A patent/ZA200600240B/en unknown
- 2004-07-16 AT AT04767691T patent/ATE349213T1/de active
- 2004-07-16 SI SI200430163T patent/SI1653963T1/sl unknown
- 2004-07-16 PL PL04767691T patent/PL1653963T3/pl unknown
- 2004-07-16 DE DE602004003955T patent/DE602004003955T2/de not_active Expired - Lifetime
- 2004-07-16 ES ES04767691T patent/ES2279435T3/es not_active Expired - Lifetime
- 2004-07-16 KR KR1020067001141A patent/KR100807480B1/ko not_active Expired - Fee Related
- 2004-07-16 MX MXPA06000641A patent/MXPA06000641A/es active IP Right Grant
- 2004-07-16 PT PT04767691T patent/PT1653963E/pt unknown
- 2004-07-16 AU AU2004258714A patent/AU2004258714A1/en not_active Abandoned
- 2004-07-16 WO PCT/FR2004/001867 patent/WO2005009442A1/fr not_active Ceased
- 2004-07-16 GE GEAP20049239A patent/GEP20074259B/en unknown
- 2004-07-16 UA UAA200601630A patent/UA85193C2/ru unknown
- 2004-07-16 HR HR20070081T patent/HRP20070081T5/xx unknown
- 2004-07-16 NZ NZ544460A patent/NZ544460A/en not_active IP Right Cessation
- 2004-07-16 EP EP04767691A patent/EP1653963B1/fr not_active Expired - Lifetime
- 2004-07-16 DK DK04767691T patent/DK1653963T3/da active
- 2004-07-16 CA CA2532631A patent/CA2532631C/fr not_active Expired - Fee Related
2005
- 2005-12-27 MA MA28688A patent/MA27864A1/fr unknown
2006
- 2006-02-16 NO NO20060743A patent/NO332776B1/no not_active IP Right Cessation
2007
- 2007-02-13 CY CY20071100190T patent/CY1106013T1/el unknown

Also Published As

Publication number	Publication date
FR2857594A1 (fr)	2005-01-21
HRP20070081T3 (hr)	2007-04-30
HK1094153A1 (zh)	2007-03-23
DK1653963T3 (da)	2007-04-10
KR100807480B1 (ko)	2008-02-25
NO20060743L (no)	2006-02-16
CY1106013T1 (el)	2011-04-06
KR20060031689A (ko)	2006-04-12
PL1653963T3 (pl)	2007-02-28
ATE349213T1 (de)	2007-01-15
MA27864A1 (fr)	2006-04-03
JP2007516947A (ja)	2007-06-28
ZA200600240B (en)	2007-03-28
HRP20070081T5 (hr)	2007-08-31
ES2279435T3 (es)	2007-08-16
CN100540004C (zh)	2009-09-16
BRPI0412681A (pt)	2006-10-03
EA011041B1 (ru)	2008-12-30
CA2532631A1 (fr)	2005-02-03
EP1653963B1 (fr)	2006-12-27
UA85193C2 (ru)	2009-01-12
GEP20074259B (en)	2007-12-10
NZ544460A (en)	2008-04-30
MXPA06000641A (es)	2006-03-30
NO332776B1 (no)	2013-01-14
DE602004003955D1 (de)	2007-02-08
CA2532631C (fr)	2011-01-04
PT1653963E (pt)	2007-02-28
MY137747A (en)	2009-03-31
CN1819828A (zh)	2006-08-16
US20060204449A1 (en)	2006-09-14
WO2005009442A1 (fr)	2005-02-03
DE602004003955T2 (de)	2007-12-06
FR2857594B1 (fr)	2005-09-16
AR046808A1 (es)	2005-12-28
EP1653963A1 (fr)	2006-05-10
EA200600172A1 (ru)	2006-06-30
AU2004258714A1 (en)	2005-02-03

Publication	Publication Date	Title
GB2394894B (en)	2005-08-31	New use for pharmaceutical composition
AU2003291103A8 (en)	2004-06-15	Pharmaceutical composition
IL164547A0 (en)	2005-12-18	Pharmaceutical composition
IL176248A0 (en)	2006-10-05	N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
GB0300427D0 (en)	2003-02-05	Pharmaceutical composition
HU0301154D0 (en)	2003-07-28	Pharmaceutical composition
AU2003250372A8 (en)	2004-01-06	Pharmaceutical composition
GB2400565B (en)	2005-03-02	Nasal drug delivery
GB0307866D0 (en)	2003-05-14	Pharmaceutical composition
GB0304636D0 (en)	2003-04-02	Pharmaceutical composition for nasal delivery
EP1699458A4 (en)	2012-04-25	PHARMACEUTICAL COMPOSITION
GB0329232D0 (en)	2004-01-21	Pharmaceutical composition
GB0317663D0 (en)	2003-09-03	Pharmaceutical composition
GB0300885D0 (en)	2003-02-12	Pharmaceutical composition
EP1600445A4 (en)	2008-06-11	CURATIVE PREPARATION
PL1653963T3 (pl)	2007-02-28	Donosowa kompozycja farmaceutyczna pirybedilu
GB0306933D0 (en)	2003-04-30	Pharmaceutical composition
GB0307869D0 (en)	2003-05-14	Pharmaceutical composition
GB0307862D0 (en)	2003-05-14	Pharmaceutical composition
GB0307864D0 (en)	2003-05-14	Pharmaceutical composition
GB0307867D0 (en)	2003-05-14	Pharmaceutical composition
GB0217703D0 (en)	2002-09-11	Pharmaceutical composition
GB0307865D0 (en)	2003-05-14	Pharmaceutical composition
GB0305598D0 (en)	2003-04-16	Pharmaceutical composition
GB0317666D0 (en)	2003-09-03	Pharmaceutical composition